KRAS G13A [plasma membrane]

Stable Identifier
R-HSA-9649632
Type
Protein [EntityWithAccessionedSequence]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
Literature References
PubMed ID Title Journal Year
18946061 K-ras mutations and benefit from cetuximab in advanced colorectal cancer

Chalchal, H, Khambata-Ford, S, Shepherd, L, Simes, RJ, Tu, D, Moore, MJ, Au, HJ, Shapiro, JD, Karapetis, CS, O'Callaghan, CJ, Tebbutt, NC, Jonker, DJ, Robitaille, S, Zalcberg, JR, Price, TJ, Langer, C

N. Engl. J. Med. 2008
External Reference Information
External Reference
Gene Names
KRAS, KRAS2, RASK2
Chain
chain:1-186, initiator methionine:, chain:2-186, propeptide:187-189
Participates
Other forms of this molecule
Modified Residues
Name
glycine 13 replaced with L-alanine
Coordinate
13
PsiMod
A protein modification that effectively converts a source amino acid residue to an L-alanine.
A protein modification that effectively removes or replaces an glycine.
Disease
Name Identifier Synonyms
colorectal cancer DOID:9256
Cross References
COSMIC
Interactors (13)
Accession #Entities Entities Confidence Score Evidence (IntAct)
 UniProt:P04049 RAF1  20 0.695 6
 UniProt:Q99755 PIP5K1A  1 0.661 9
 UniProt:P15056 BRAF  20 0.615 4
 UniProt:Q96II5 Q96II5      0.556 3
 UniProt:P50749 RASF2      0.544 2
 UniProt:P61586 RHOA  6 0.519 2
 UniProt:O75915 ARL6IP5  1 0.519 2
 UniProt:P10398 ARAF  4 0.483 2
 UniProt:P28288 ABCD3  2 0.483 2
 UniProt:P01111 NRAS  20 0.483 2
 UniProt:Q7KZI7 MARK2      0.483 2
 UniProt:Q9UQB8 BAIAP2  1 0.483 2
 ChEBI:16618 1-PHOSPHATIDYL-1D-MYO-INOSITOL 3,4,5-TRISPHOSPHATE      0.462 2
Cite Us!